L3Harris Technologies
LHX
$330.22
-0.43%
L3Harris Technologies, Inc. is a major aerospace and defense contractor that designs and manufactures a diverse portfolio of advanced technology products, including software-defined radios, uncrewed aerial vehicles, sensors, avionics, space-based systems, missiles, and solid rocket motors. The company is a significant player in the defense industrial base, distinguished by its role in critical communications infrastructure and its position as a key integrator of complex mission systems. The current investor narrative is dominated by structural increases in global defense budgets driven by geopolitical tensions, with recent headlines highlighting commitments from major contractors to dramatically ramp up production of advanced weaponry, positioning L3Harris to benefit from a sustained multi-year tailwind in defense spending.…
LHX
L3Harris Technologies
$330.22
Related headlines
Investment Opinion: Should I buy LHX Today?
Rating & Thesis: Hold. LHX is a high-quality defense contractor positioned for a multi-year tailwind, but its premium valuation and recent momentum deceleration suggest waiting for a better entry point or clearer evidence of earnings acceleration. The bullish analyst sentiment (Overweight/Buy ratings from major firms) and implied upside to a forward PE-derived target are positive, but fully priced in.
Supporting Evidence: The stock trades at a forward PE of 25.77x, which is high for an industrial but reflects growth expectations. Revenue growth is modest at 2.26% YoY but showed a sequential quarterly uptrend. Profitability is volatile, with net margin compressing to 5.31% in Q4. The strong TTM FCF of $2.68B and healthy D/E of 0.53 are supportive. The implied analyst price target of ~$522 (using forward PE and consensus EPS) suggests significant upside, but this is contingent on perfect execution.
Risks & Conditions: The two biggest risks are valuation multiple contraction and failure to expand margins. This Hold rating would upgrade to a Buy if the forward PE compresses below 22x (offering a margin of safety) or if quarterly revenue growth accelerates sustainably above 5% with margin expansion. It would downgrade to a Sell if revenue growth turns negative or if the net margin consistently falls below 5%. Relative to its history and the sector, the stock is currently overvalued, pricing in near-flawless execution of the defense spending thesis.
Sign up to view all
LHX 12-Month Price Forecast
The outlook is balanced with a slight tilt toward the base case. The fundamental backdrop is favorable due to defense tailwinds, but the stock's powerful rally has left it valued for perfection. The key will be the translation of budget rhetoric into tangible, high-margin orders in the coming quarters. The stance would upgrade to bullish on evidence of accelerating organic revenue growth (above 5%) and expanding margins. It would turn bearish if the next quarterly report shows further margin compression or a growth slowdown, confirming the valuation is unsustainable.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on L3Harris Technologies's 12-month outlook, with a consensus price target around $429.29 and implied upside of +30.0% versus the current price.
Average Target
$429.29
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$264 - $429
Analyst target range
Analyst coverage for LHX appears limited in the provided dataset, with only 7 analysts cited in the estimates data and a handful of recent institutional ratings. The consensus sentiment leans bullish, with recent actions from Citigroup (Buy), JP Morgan (Overweight), and Morgan Stanley (Overweight) reaffirming positive ratings. The average target price is not explicitly provided in the data, but the estimated EPS average for the forward period is $20.27. Using the forward PE of 25.77x implies a consensus price target of approximately $522, which would represent significant upside from the current $350.35, though this is a derived figure and should be treated with caution. The target range, as inferred from estimated EPS, has a low of $19.92 and a high of $20.72, which is a very tight band suggesting high analyst conviction in near-term earnings forecasts. The high target likely assumes successful execution on margin expansion and revenue growth from new defense contracts, while the low target may factor in potential integration challenges or program delays. The recent institutional ratings show stability, with no downgrades in the sample, only reaffirmations and one upgrade (Morgan Stanley to Overweight in December 2025), reinforcing a constructive view. The limited number of explicit coverage calls suggests LHX, despite its large market cap, may have less ubiquitous coverage than some mega-cap peers, which can sometimes lead to periods of higher volatility based on company-specific news flow.
Bulls vs Bears: LHX Investment Factors
The bull case, driven by structural defense budget increases and strong cash flow, currently holds stronger evidence given the stock's powerful long-term uptrend and embedded earnings growth expectations. However, the bear case presents a compelling counter-argument centered on valuation risk, with the stock trading at a premium PE near its historical highs. The single most important tension in the investment debate is whether the company's future earnings growth can accelerate sufficiently to justify and sustain its current elevated valuation multiple, or if the stock is simply overextended after a 60% annual rally. The resolution of this tension hinges on the translation of defense budget rhetoric into concrete, high-margin contracts for L3Harris.
Bullish
- Powerful Defense Spending Tailwind: Geopolitical tensions are driving structural increases in global defense budgets, with major contractors committing to quadruple production of advanced weaponry. This creates a sustained multi-year tailwind for L3Harris's diverse portfolio in missiles, space, and C4ISR systems.
- Strong Free Cash Flow Generation: The company generates robust free cash flow, with TTM FCF of $2.68 billion. This provides ample internal funding for dividends, share buybacks, and strategic investments, underpinning shareholder returns and financial flexibility.
- Earnings Growth Acceleration Priced In: The forward PE of 25.77x is significantly lower than the trailing PE of 35.53x, implying the market expects a substantial earnings recovery. Analyst consensus EPS for the forward period is $20.27, suggesting strong projected growth.
- Healthy Balance Sheet: A debt-to-equity ratio of 0.53 indicates a conservative capital structure. The current ratio of 1.19 shows adequate short-term liquidity, reducing financial risk during a period of potential investment and integration.
Bearish
- Premium Valuation at Historical Highs: The trailing PE of 35.53x is near the upper end of its historical range and well above typical industrial/mid-20s multiples. This leaves little room for multiple expansion and increases sensitivity to earnings disappointments.
- Recent Margin Pressure: Q4 2025 net margin compressed to 5.31% from 8.16% in Q3, and gross margin of 25.60% shows pressure from the 26.40% in Q3. This volatility suggests potential integration costs or unfavorable product mix.
- Modest Revenue Growth: Q4 2025 revenue of $5.65B grew only 2.26% year-over-year. While the quarterly trajectory is upward, the growth rate is modest for a stock trading at a high-growth premium.
- Recent Momentum Deceleration: The stock has underperformed the market recently, down -4.89% over the past month vs. SPY's +7.36%, a -12.25 percentage point underperformance. This suggests profit-taking and a potential consolidation phase after a powerful rally.
LHX Technical Analysis
The stock is in a sustained long-term uptrend, evidenced by a 1-year price change of +60.55%, significantly outperforming the broader market. As of the latest close at $350.35, the price is trading at approximately 92% of its 52-week high of $379.23, indicating it is near the upper bound of its annual range and reflecting strong bullish momentum, though also suggesting potential for near-term consolidation or resistance. The stock has experienced a notable pullback from its March 2026 peak, with the current price representing a -11.23% maximum drawdown from recent highs, signaling a cooling-off period after a powerful rally. Recent short-term momentum has diverged negatively from the powerful longer-term trend, with the stock down -4.89% over the past month, underperforming the SPY's +7.36% gain by a substantial -12.25 percentage points. The 3-month performance is a modest +1.12%, also lagging the market's +2.67% return, indicating a clear deceleration and potential profit-taking phase following the explosive gains seen in January and February of 2026. This divergence suggests the stock is undergoing a healthy consolidation or correction within its broader uptrend rather than a fundamental reversal. Key technical support is anchored at the 52-week low of $208.11, while immediate resistance is at the 52-week high of $379.23. A decisive breakout above $379 would signal a resumption of the primary uptrend, while a breakdown below the recent consolidation range near $340 could indicate a deeper correction. The stock's beta of 0.746 indicates it is approximately 25% less volatile than the broader market, which is atypical for a defense name but may reflect its large-cap, diversified profile and lower sensitivity to general market swings compared to pure-play growth stocks.
Beta
0.75
0.75x market volatility
Max Drawdown
-12.8%
Largest decline past year
52-Week Range
$208-$379
Price range past year
Annual Return
+52.7%
Cumulative gain past year
| Period | LHX Return | S&P 500 |
|---|---|---|
| 1m | -6.0% | +8.5% |
| 3m | -6.9% | +2.8% |
| 6m | +12.6% | +4.6% |
| 1y | +52.7% | +32.3% |
| ytd | +8.5% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LHX Fundamental Analysis
Revenue growth has been steady but modest, with the most recent quarterly revenue (Q4 2025) of $5.65 billion representing a 2.26% year-over-year increase. Examining the quarterly sequence from Q1 2025 ($5.13B) to Q4 2025 ($5.65B) shows a consistent upward trajectory, with growth accelerating from the Q1 base. Segment data reveals a balanced portfolio, with Space and Airborne Systems ($6.95B) and Integrated Mission Systems ($6.63B) as the largest contributors, suggesting growth is being driven across its core defense franchises rather than by a single segment. The company is profitable, reporting net income of $300 million for Q4 2025. However, profitability metrics show some quarterly volatility; the net margin for Q4 was 5.31%, a compression from the 8.16% net margin reported in Q3 2025. The gross margin for the latest quarter was 25.60%, which is consistent with its trailing gross margin of 25.73%. The trend from recent quarters (Q3 gross margin of 26.40%, Q2 of 21.34%) indicates some margin pressure, likely tied to product mix and integration costs from acquisitions like Aerojet Rocketdyne. The balance sheet is healthy with a manageable debt-to-equity ratio of 0.53, indicating a conservative capital structure. The company generates robust free cash flow, with TTM free cash flow of $2.68 billion, providing ample internal funding for dividends, share buybacks, and strategic investments. Return on Equity (ROE) stands at 8.18%, which is reasonable for a capital-intensive industrial business. The current ratio of 1.19 suggests adequate short-term liquidity to meet obligations.
Quarterly Revenue
$5.6B
2026-01
Revenue YoY Growth
+0.02%
YoY Comparison
Gross Margin
+0.25%
Latest Quarter
Free Cash Flow
$2.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LHX Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 35.53x, while the forward PE is notably lower at 25.77x. This significant gap implies the market is pricing in a substantial recovery and acceleration in earnings growth over the next twelve months, aligning with the bullish defense spending narrative. Compared to sector averages, L3Harris trades at a premium. Its trailing PE of 35.53x is well above the typical industrial/mid-20s range, and its Price-to-Sales (PS) ratio of 2.61x also sits at the higher end for defense contractors. This premium is likely justified by the company's strategic positioning in high-growth areas like space, missiles, and C4ISR, its strong free cash flow generation, and the favorable sector tailwinds from rising global defense budgets. Historically, the stock's current trailing PE of 35.53x is near the upper end of its own range observed over the past several years, where it has typically fluctuated between the low-20s and mid-30s. Trading near historical highs suggests the market has already priced in a significant portion of the optimistic growth expectations, leaving less room for multiple expansion and increasing the stock's sensitivity to any earnings disappointments or a shift in the defense spending outlook.
PE
35.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -33x~63x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is margin volatility, as evidenced by the Q4 2025 net margin compression to 5.31% from 8.16% the prior quarter. While revenue growth is steady at ~2% YoY, it is modest, and the company's valuation demands an acceleration. The balance sheet is healthy with a D/E of 0.53, but integration costs from acquisitions like Aerojet Rocketdyne could continue to pressure profitability in the near term. The current ratio of 1.19 indicates adequate but not excessive liquidity.
Market & Competitive Risks: The paramount market risk is valuation compression. Trading at a trailing PE of 35.53x, a premium to both sector averages and its own historical range, LHX is vulnerable to a de-rating if growth fails to materialize as expected. The stock's beta of 0.746 indicates lower volatility than the market, but this may not protect against sector-specific rotations out of defense names if geopolitical tensions ease. Competitive risks include the Pentagon's shift toward a more competitive vendor marketplace (SHIELD contract), which could pressure pricing, and potential disruption from new entrants in autonomous systems.
Worst-Case Scenario: The worst-case scenario involves a combination of delayed defense contract awards, continued margin pressure from integration issues, and a broader market de-rating of premium-valued industrials. This could lead to missed earnings estimates, multiple compression toward its historical low-20s PE, and a retracement toward its 52-week low. From the current price of $350.35, a realistic severe downside could see the stock fall -35% to -40%, revisiting the $220-$230 range, which aligns with a PE in the low-20s applied to current earnings and is above the 52-week low of $208.11.
FAQ
The key risks are: 1) Valuation Risk: The primary risk is multiple contraction from its elevated PE of 35.53x if growth disappoints. 2) Execution Risk: Recent margin volatility (Q4 net margin 5.31% vs. Q3 8.16%) suggests potential integration or cost challenges. 3) Geopolitical/Budget Risk: The thesis depends on sustained defense spending increases; any de-escalation or budget delays could hurt sentiment. 4) Competitive Risk: Shifts in Pentagon procurement (e.g., SHIELD contract) could increase pricing pressure. The valuation risk is currently the most severe given the stock's price level.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock trading between $340 and $379, as steady execution meets high expectations. The Bull Case (30% probability) targets $379 to $420 on accelerated growth and margin expansion. The Bear Case (15% probability) warns of a drop to $230-$300 on earnings disappointments and multiple compression. The most likely outcome is the Base Case, where the stock consolidates recent gains as the company works to justify its valuation with gradually improving fundamentals.
LHX appears overvalued relative to its recent history and sector peers. Its trailing PE of 35.53x is near the upper end of its historical range and above typical industrial multiples. The forward PE of 25.77x is more reasonable but still implies high growth expectations that are not yet evident in its modest 2.26% revenue growth. The market is paying a premium for anticipated future earnings acceleration from defense spending. The valuation implies the market expects flawless execution and a significant near-term profit ramp, leaving the stock vulnerable to disappointment.
LHX is a Hold, not a clear buy at current levels. While the long-term defense spending thesis is compelling and the company is financially strong, the stock's premium valuation (35.53x trailing PE) leaves little margin for error. The implied upside to analyst targets is significant, but it is predicated on perfect execution of earnings growth. For investors with a long-term horizon and high conviction in the defense cycle, it could be a good buy on a pullback toward the $320-$330 range. For others, waiting for evidence of accelerating revenue growth and margin expansion is prudent.
LHX is more suitable for a long-term investment horizon of 3-5 years. Its thesis is based on a multi-year defense spending cycle, and short-term volatility is likely as the market grapples with quarterly execution against high expectations. The stock's beta of 0.746 indicates lower volatility than the market, which supports a long-term hold. The company's dividend (1.58% yield) and share buyback capacity (supported by $2.68B FCF) also cater to long-term investors. A minimum holding period of 18-24 months is suggested to allow the fundamental story to play out.